BioSpace News Archive

Tarsus Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced Bobak Azamian, M.D., Ph.D., President and Chief Executive Officer of Tarsus, will present an overview of the company at the BofA Securities 2021 Virtual Health Care Conference.

BioVie Inc., a clinical-stage company developing innovative drug therapies for chronic debilitating liver diseases, announced the acquisition of the biopharmaceutical assets of NeurMedix, Inc., a San Diego based privately held clinical-stage pharmaceutical company focused on novel therapeutic assets for the treatment of neurodegenerative and neurological disorders, as well as certain cancers.

Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that it will release financial results for the first quarter of 2021 after the close of trading on Tuesday, May 11, 2021.

Granted Priority Medicines designation by the European Medicines Agency for CTX001™ for transfusion-dependent beta thalassemia (TDT)

Iridex Corporation, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced the Company will release financial results for the first quarter of 2021 after the close of trading on Tuesday, May 11, 2021.

Amgen announced financial results for the first quarter of 2021.

AtriCure, Inc., a leading innovator in treatments for atrial fibrillation and left atrial appendage management, announced first quarter 2021 financial results.

TTX-3360, an antisense oligonucleotide delivered by intracerebroventricular (ICV) injection, targets MSH3, a component of the DNA Damage Response pathway

The Board of Directors of BD has declared a quarterly dividend of $0.83 per common share, payable on June 30, 2021 to holders of record on June 9, 2021.

Sangamo Therapeutics, Inc., a genomic medicine company, announced that the Company has scheduled the release of its first quarter 2021 financial results after the market closes on Tuesday, May 4, 2021.